Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report

Arteriosclerosis, Thrombosis, and Vascular Biology
Daniel S HippeXue-Qiao Zhao

Abstract

To assess whether Lp(a) (lipoprotein(a)) levels and other lipid levels were predictive of progression of atherosclerosis burden as assessed by carotid magnetic resonance imaging in subjects who have been treated with LDL-C (low-density lipoprotein cholesterol)-lowering therapy and participated in the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes). AIM-HIGH was a randomized, double-blind study of subjects with established vascular disease, elevated triglycerides, and low HDL-C (high-density lipoprotein cholesterol). One hundred fifty-two AIM-HIGH subjects underwent both baseline and 2-year follow-up carotid artery magnetic resonance imaging. Plaque burden was measured by the percent wall volume (%WV) of the carotid artery. Associations between annualized change in %WV with baseline and on-study (1 year) lipid variables were evaluated using multivariate linear regression and the Bonferroni correction to account for multiple comparisons. Average %WV at baseline was 41.6±6.8% and annualized change in %WV over 2 years ranged from -3.2% to 3.7% per year (mean: 0.2±1.1% per year; P=0.032). Increases in %WV were significantly associated with higher ...Continue Reading

References

Jun 19, 1987·JAMA : the Journal of the American Medical Association·D H BlankenhornL Cashin-Hemphill
Jan 5, 2002·The New England Journal of Medicine·B G BrownJ J Albers
Feb 24, 2009·Nature Clinical Practice. Cardiovascular Medicine·Beate R JaegerUNKNOWN Group of Clinical Investigators
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Pia R KamstrupBørge G Nordestgaard
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Oct 23, 2010·European Heart Journal·Børge G NordestgaardUNKNOWN European Atherosclerosis Society Consensus Panel
Sep 24, 2011·Stroke; a Journal of Cerebral Circulation·Nathalie NasrVincent Larrue
Nov 17, 2011·The New England Journal of Medicine·William E BodenWilliam Weintraub
Jun 16, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·J David Spence, Marlys Koschinsky
Jun 6, 2013·Stroke; a Journal of Cerebral Circulation·Thapat WannarongJ David Spence
Jul 6, 2013·Journal of Lipid Research·Gregor LeibundgutSotirios Tsimikas
Mar 20, 2014·The American Journal of Cardiology·Alberto ZambonJohn D Brunzell
Jul 19, 2014·Stroke; a Journal of Cerebral Circulation·Arna van EngelenMarleen de Bruijne
Mar 17, 2015·The New England Journal of Medicine·Jennifer G RobinsonUNKNOWN ODYSSEY LONG TERM Investigators
Mar 17, 2015·The New England Journal of Medicine·Marc S SabatineUNKNOWN Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators
Nov 6, 2015·Journal of Lipid Research·Mark J GrahamSotirios Tsimikas
Nov 16, 2016·JAMA : the Journal of the American Medical Association·Stephen J NichollsSteven E Nissen
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators

❮ Previous
Next ❯

Citations

Dec 27, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Yunosuke MatsuuraKarin E Bornfeldt
Aug 15, 2019·Scientific Reports·Sílvia ParedesIsabel Palma
Mar 28, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Congqing WuHong S Lu
Feb 8, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Brian T SteffenMichael Y Tsai
Mar 9, 2019·Current Atherosclerosis Reports·Željko Reiner
May 23, 2019·Clinical and Experimental Hypertension : CHE·Bo Youn WonYoung-Sang Kim
Jan 1, 2021·Archives of Medical Research·Georgia AnastasiouEvangelos Liberopoulos
Jan 31, 2021·Journal of Cardiovascular Development and Disease·Narek A TmoyanSergei N Pokrovsky
Feb 19, 2021·Nature Communications·William YuanIsaac S Kohane
Jul 31, 2020·Advanced Drug Delivery Reviews·Josefin SoppertHeidi Noels
Aug 15, 2021·European Journal of Preventive Cardiology·Ioannis ParthymosMatilda Florentin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

© 2022 Meta ULC. All rights reserved